Privia Health Group Files 8-K/A Amendment

Ticker: PRVA · Form: 8-K/A · Filed: 2024-05-29T00:00:00.000Z

Sentiment: neutral

Topics: amendment, filing, corporate-governance

TL;DR

Privia Health Group filed an amendment to a shareholder vote filing. Check for updates.

AI Summary

Privia Health Group, Inc. filed an amendment (8-K/A) on May 29, 2024, to a previous filing concerning matters submitted to a vote of security holders. The original event date was May 22, 2024. The company is incorporated in Delaware and headquartered in Arlington, Virginia.

Why It Matters

This filing is an amendment to a previous report, indicating a correction or addition to information previously disclosed regarding security holder votes.

Risk Assessment

Risk Level: low — This is an amendment to a previous filing, likely for administrative or minor corrections, and does not appear to introduce new material risks.

Key Players & Entities

FAQ

What type of filing is this?

This is a Form 8-K/A, which is an amendment to a Current Report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

What is the exact name of the company filing this amendment?

The exact name of the registrant is Privia Health Group, Inc.

When was the earliest event reported in this filing?

The earliest event reported was on May 22, 2024.

On what date was this amendment filed?

This amendment was filed on May 29, 2024.

Where are Privia Health Group, Inc.'s principal executive offices located?

Privia Health Group, Inc.'s principal executive offices are located at 950 N. Glebe Rd., Suite 700, Arlington, Virginia 22203.

From the Filing

0001759655-24-000099.txt : 20240529 0001759655-24-000099.hdr.sgml : 20240529 20240529160602 ACCESSION NUMBER: 0001759655-24-000099 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240522 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20240529 DATE AS OF CHANGE: 20240529 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Privia Health Group, Inc. CENTRAL INDEX KEY: 0001759655 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40365 FILM NUMBER: 24998345 BUSINESS ADDRESS: STREET 1: 950 N. GLEBE RD., SUITE 700 CITY: ARLINGTON STATE: VA ZIP: 22203 BUSINESS PHONE: 571-366-8850 MAIL ADDRESS: STREET 1: 950 N. GLEBE RD., SUITE 700 CITY: ARLINGTON STATE: VA ZIP: 22203 FORMER COMPANY: FORMER CONFORMED NAME: PH Group Parent Corp. DATE OF NAME CHANGE: 20181120 8-K/A 1 prva-20240522.htm 8-K/A prva-20240522 0001759655 TRUE 0001759655 2024-05-22 2024-05-22 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 8-K/A (Amendment No. 1) _________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2024 _________________________ Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) _________________________ Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organization) (Commission File No.) (I.R.S. Employer Identification No.) 950 N. Glebe Rd., Suite 700 Arlington, Virginia 22203 (Address of Principal Executive Offices) (Zip Code) ( 571 ) 366-8850 Registrant's telephone number, including area code Not Applicable (Former name, former address and former fiscal year, if changed since last report) Check the appropriate box below if the form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2 (b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value per share PRVA The Nasdaq Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Explanatory Note On May 22, 2024, Privia Health Group, Inc. (the “Company”) filed a Current Report on Form 8-K with the Securities and Exchange Commission (the “SEC”) disclosing, among other things, the results of its 2024 annual meeting of shareholders (the “Original Report”) held on May 22, 2024 (the “Annual Meeting”). This Current Report on Form 8-K/A amends and restates Item 5.07 of the Original Report to correct the voting results reported for Proposal No. 2, for which the number of Votes Against was inadvertently overstated in the Original Report. As required by Rule 12b-15 under th

View on Read The Filing